Target Name: C-C chemokine receptor
NCBI ID: P5796
Review Report on C-C chemokine receptor Target / Biomarker Content of Review Report on C-C chemokine receptor Target / Biomarker
C-C chemokine receptor
Other Name(s): CCR | Chemokine CC receptor | C-C chemokine receptor

CCR: A Role in The Immune System and Potential Drug Target

C-C chemokine receptor (nonspecified subtype), also known as CCR, is a protein that plays a crucial role in the immune system. It is a member of the chemokine receptor family, which is a group of transmembrane proteins that are involved in the signaling of various cellular processes, including cell adhesion, migration, and inflammation. CCR is one of the six known chemokine receptors that have been identified in humans, and it is expressed in a wide range of tissues and cells throughout the body.

The CCR is a protein that consists of an extracellular domain, a transmembrane region, and an intracellular domain. The extracellular domain of CCR consists of a single transmembrane protein that is involved in the formation of the receptor complex. The transmembrane region of CCR consists of a unique ionotropic ion channel that is involved in the signaling of chemokines. The intracellular domain of CCR consists of a protein that is involved in the interaction with intracellular signaling pathways.

CCR is involved in the regulation of various cellular processes, including immune responses, cell adhesion, and cell migration. It is well established that CCR plays a key role in the regulation of T cell responses, which are a crucial part of the immune system. CCR is also involved in the regulation of natural killer (NK) cell responses, which are important for immune surveillance of the body.

In addition to its role in the immune system, CCR is also involved in the regulation of various signaling pathways that are important for cellular processes throughout the body. For example, CCR is involved in the regulation of cell proliferation, differentiation, and survival. It is also involved in the regulation of cell signaling pathways that are important for cell adhesion, migration, and survival.

As a drug target, CCR is an attractive target for researchers because of its involvement in various cellular processes that are important for human health and disease. For example, CCR is involved in the regulation of T cell responses, which are important for immune surveillance of the body. It is also involved in the regulation of natural killer (NK) cell responses, which are important for immune surveillance of the body.

In addition to its potential as a drug target, CCR is also an attractive biomarker for various diseases. For example, CCR is involved in the regulation of T cell responses, which are important for immune surveillance of the body. Therefore, changes in the level of CCR expression in certain tissues or cells can be an indication of the presence of certain diseases. For example, increased levels of CCR expression in the lungs can be an indication of chronic obstructive pulmonary disease (COPD).

In conclusion, C-C chemokine receptor (nonspecified subtype) is a protein that plays a crucial role in the immune system and is involved in the regulation of various cellular processes. It is a potential drug target and biomarker for various diseases. Further research is needed to fully understand the role of CCR in the immune system and its potential as a drug and biomarker.

Protein Name: C-C Chemokine Receptor (nonspecified Subtype)

The "C-C chemokine receptor Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about C-C chemokine receptor comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

C10orf105 | C10orf113 | C10orf120 | C10orf126 | C10orf143 | C10orf53 | C10orf55 | C10orf62 | C10orf67 | C10orf71 | C10orf71-AS1 | C10orf82 | C10orf88 | C10orf88B | C10orf90 | C10orf95 | C10orf95-AS1 | C11orf16 | C11orf21 | C11orf24 | C11orf40 | C11orf42 | C11orf52 | C11orf54 | C11orf58 | C11orf65 | C11orf68 | C11orf71 | C11orf80 | C11orf86 | C11orf87 | C11orf91 | C11orf96 | C11orf97 | C11orf98 | C12orf29 | C12orf4 | C12orf40 | C12orf42 | C12orf43 | C12orf50 | C12orf54 | C12orf56 | C12orf57 | C12orf60 | C12orf74 | C12orf75 | C12orf76 | C13orf42 | C13orf46 | C14orf119 | C14orf132 | C14orf178 | C14orf180 | C14orf28 | C14orf39 | C14orf93 | C15orf32 | C15orf39 | C15orf40 | C15orf48 | C15orf61 | C15orf62 | C16orf46 | C16orf54 | C16orf74 | C16orf78 | C16orf82 | C16orf86 | C16orf87 | C16orf89 | C16orf90 | C16orf92 | C16orf95 | C16orf96 | C17orf100 | C17orf107 | C17orf49 | C17orf50 | C17orf58 | C17orf67 | C17orf75 | C17orf78 | C17orf80 | C17orf97 | C17orf98 | C17orf99 | C18orf21 | C18orf25 | C18orf32 | C18orf54 | C18orf63 | C19orf12 | C19orf18 | C19orf25 | C19orf33 | C19orf38 | C19orf44 | C19orf47 | C19orf48